Apyx Medical Corporation Common Stock (APYX) — Analysis Summary
Apyx Medical Corporation Common Stock (APYX) has a market cap of $167.29M with year-over-year revenue growth of +9.9%. Net margin stands at -21.2%. The stock trades at a P/E ratio of -18.2.
Key Takeaways
- Revenue changed +9.9% year-over-year
- Net margin of -21.2%
- P/E ratio of -18.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, APYX posted revenue growth of +9.9% and trades at a P/E of -18.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.